Wednesday, July 24, 2024
Home Tags Wuhan Zhong Yuan Rui De Biologics

Tag: Wuhan Zhong Yuan Rui De Biologics

CSL to buy majority stake in a leading Chinese plasma fractionator

Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in...
Advertisement

FabreLEC

Custom Patches Iraq

Featured Article

Beyond insights: CRM’s transformative role in sustainable manufacturing

Manufacturing companies worldwide are increasingly gearing up for a significant transformation with environmental sustainability at the centre. This comes amid stronger environmental regulations, a shift in consumer behaviour, and the industrial sector delves deeper into Industry 4.0.